Literature DB >> 23397463

The vascular endothelium in diabetes and its potential as a therapeutic target.

Zhenqi Liu1.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23397463      PMCID: PMC3594359          DOI: 10.1007/s11154-013-9238-8

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  27 in total

1.  Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells.

Authors:  G Zeng; F H Nystrom; L V Ravichandran; L N Cong; M Kirby; H Mostowski; M J Quon
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

2.  Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells.

Authors:  Monica Montagnani; Inga Golovchenko; Injune Kim; Gou Young Koh; Marc L Goalstone; Ameya N Mundhekar; Mette Johansen; Dennis F Kucik; Michael J Quon; Boris Draznin
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

3.  Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo.

Authors:  Lucy H Clerk; Stephen Rattigan; Michael G Clark
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

4.  Processing of insulin by bovine endothelial cells in culture. Internalization without degradation.

Authors:  I Jialal; G L King; S Buchwald; C R Kahn; M Crettaz
Journal:  Diabetes       Date:  1984-08       Impact factor: 9.461

5.  Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium.

Authors:  Etto C Eringa; Coen D A Stehouwer; Geerten P van Nieuw Amerongen; Lenneke Ouwehand; Nico Westerhof; Pieter Sipkema
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04-01       Impact factor: 4.733

6.  Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles.

Authors:  Etto C Eringa; Coen D A Stehouwer; Thomas Merlijn; Nico Westerhof; Pieter Sipkema
Journal:  Cardiovasc Res       Date:  2002-12       Impact factor: 10.787

7.  Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin.

Authors:  M A Vincent; E J Barrett; J R Lindner; M G Clark; S Rattigan
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-07       Impact factor: 4.310

8.  Stimulation of endothelin-1 gene expression by insulin in endothelial cells.

Authors:  F J Oliver; G de la Rubia; E P Feener; M E Lee; M R Loeken; T Shiba; T Quertermous; G L King
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

9.  Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo.

Authors:  Michelle A Vincent; Lucy H Clerk; Jonathan R Lindner; Alexander L Klibanov; Michael G Clark; Stephen Rattigan; Eugene J Barrett
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461

10.  Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism.

Authors:  Weidong Chai; Zhenhua Dong; Nasui Wang; Wenhui Wang; Lijian Tao; Wenhong Cao; Zhenqi Liu
Journal:  Diabetes       Date:  2012-02-22       Impact factor: 9.461

View more
  5 in total

Review 1.  Vascular function, insulin action, and exercise: an intricate interplay.

Authors:  Chao Zheng; Zhenqi Liu
Journal:  Trends Endocrinol Metab       Date:  2015-02-23       Impact factor: 12.015

Review 2.  Adiponectin and insulin cross talk: the microvascular connection.

Authors:  Lina Zhao; Zhuo Fu; Zhenqi Liu
Journal:  Trends Cardiovasc Med       Date:  2014-08-07       Impact factor: 6.677

3.  Glucagon-like peptide 1 recruits muscle microvasculature and improves insulin's metabolic action in the presence of insulin resistance.

Authors:  Weidong Chai; Xingxing Zhang; Eugene J Barrett; Zhenqi Liu
Journal:  Diabetes       Date:  2014-03-21       Impact factor: 9.461

4.  PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment.

Authors:  Longhua Liu; Lihong Fan; Michelle Chan; Michael J Kraakman; Jing Yang; Yong Fan; Nicole Aaron; Qianfen Wan; Maria Alicia Carrillo-Sepulveda; Alan R Tall; Ira Tabas; Domenico Accili; Li Qiang
Journal:  Diabetes       Date:  2020-05-14       Impact factor: 9.337

5.  Diabetes pathogenesis and management: the endothelium comes of age.

Authors:  Kaitlin M Love; Eugene J Barrett; Steven K Malin; Jane E B Reusch; Judith G Regensteiner; Zhenqi Liu
Journal:  J Mol Cell Biol       Date:  2021-10-21       Impact factor: 6.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.